PDS Stock Recent News

Low price-to-sales stocks -- PDS, GBX, GDOT, MOS and PAGS -- show strong fundamentals and value potential for investors seeking upside returns.

Median Overall Survival (mOS) of 39.3 months in patients with CPS ≥ 1 – best published result with standard of care pembrolizumab or pembrolizumab + chemotherapy is 17.9 months*

The average of price targets set by Wall Street analysts indicates a potential upside of 32.9% in Precision Drilling (PDS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

ENVA, PDS and CYD made it to the Zacks Rank #1 (Strong Buy) value stocks list on August 18, 2025.

JHG, GBX, PDS, MOS, and PAGS boast low price-to-sales ratios, meeting strict value screens for strong upside potential.

Precision Drilling has gone precisely in the wrong direction since we first wrote on the stock. The recent quarterly results once again reinforced the view that the market is getting this wrong. We go over how we are playing it and why the odds of losing money are extremely low.

The mean of analysts' price targets for Precision Drilling (PDS) points to a 31.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Precision Drilling Corporation (NYSE:PDS ) Q2 2025 Earnings Conference Call July 30, 2025 1:00 PM ET Company Participants Carey Thomas Ford - Chief Financial Officer Kevin A. Neveu - President, CEO & Director Lavonne Zdunich - Vice President of Investor Relations Conference Call Participants Aaron MacNeil - TD Cowen, Research Division Derek John Podhaizer - Piper Sandler & Co., Research Division John Gibson - BMO Capital Markets Equity Research John Matthew Daniel - Daniel Energy Partners, LLC Keith MacKey - RBC Capital Markets, Research Division Waqar Mustafa Syed - ATB Capital Markets Inc., Research Division Operator Good day, and thank you for standing by.